title: Is oral tolerance therapy possible for haemophilia with inhibitors?
authors.forename: K
authors.initials: K
authors.lastname: Terada
authors.forename: Y
authors.initials: Y
authors.lastname: Yagi
authors.forename: T
authors.initials: T
authors.lastname: Niizuma
authors.forename: N
authors.initials: N
authors.lastname: Kataoka
mesh_terms: D000284:Administration, Oral; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D002971:Cleft Lip / Q000150:complications / Q000601:surgery; D003888:Desensitization, Immunologic; D005169:Factor VIII / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000150:complications / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D007223:Infant; D007518:Isoantibodies / Q000096:biosynthesis / Q000276:immunology*; D007519:Isoantigens / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D008297:Male; D019106:Postoperative Hemorrhage / Q000209:etiology / Q000628:therapy; D011300:Preoperative Care
chemical_list: D001779:Blood Coagulation Factors; D007518:Isoantibodies; D007519:Isoantigens; C025667:prothrombin complex concentrates; D005169:Factor VIII